设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2018 年第 2 期 第 13 卷

实时动态三维超声造影评价索拉非尼靶向治疗中晚期肝癌早期疗效的观察性研究

作者:王蓓张立平翟虹

英文作者:

单位:830000乌鲁木齐,新疆医科大学附属中医医院腹部超声科

英文单位:

关键词:肝肿瘤;实时动态三维超声造影;索拉非尼;靶向治疗

英文关键词:

  • 摘要:
  • 目的    探讨实时动态三维超声造影(3D-CEUS)在评价索拉非尼靶向治疗中晚期肝癌早期疗效中的应用价值。方法    选取2015年7月至2017年7月于新疆医科大学附属中医医院住院经临床确诊的中晚期原发性肝癌患者60例作为研究对象,均给予索拉非尼靶向治疗。治疗前首先进行肝脏增强CT检查,确定目标病灶,然后行实时动态3D-CEUS检查。比较治疗前动态3D-CEUS与2D-CEUS对患者动脉期肿瘤滋养血管的显示率及显示质量评分;比较治疗后动态3D-CEUS与2D-CEUS对肿瘤灭活诊断的敏感度、特异度和诊断正确率。结果    本研究60例原发性肝癌患者共计60个肿瘤病灶,治疗前,2D-CEUS检查观察到40个病灶的动脉期肿瘤滋养血管,显示率为66.7%(40/60),动态3D-CEUS检查观察到60个病灶的动脉期肿瘤滋养血管,显示率为100.0%(60/60),二者显示率比较差异有统计学意义(χ2=5.459,P=0.027)。治疗前,动态3D-CEUS对动脉期肿瘤滋养血管显示质量评分1分5例、2分22例、3分33例,而2D-CEUS对动脉期肿瘤滋养血管显示质量评分1分29例、2分24例、3分7例,二者差异有统计学意义(P=0.023)。治疗后,动态3D-CEUS与2D-CEUS对肿瘤灭活诊断的敏感度、特异度以及诊断正确率差异均无统计学意义(均P>0.05)。结论    2D-CEUS与实时动态3D-CEUS在评价索拉非尼靶向治疗中晚期肝癌早期疗效中均具有较高的应用价值,但是在动脉期肿瘤滋养血管显示质量评价方面,实时动态3D-CEUS效果更佳。

  • Real-time three-dimensional ultrasonography in early effectiveness evaluation of sorafenib targeted therapy for middle and advanced liver carcinoma

    Wang Bei, Zhang Liping, Zhai Hong

    Department of Abdominal Ultrasonography, Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, China

    Corresponding author: Zhai Hong, Email: 55107333@qq.com

    【Abstract】Objective    To evaluate the value of real-time three-dimensional contrast-enhanced ultrasonography(3D-CEUS) in evaluating the effectiveness of sorafenib targeted therapy for middle and advanced liver carcinoma. Methods    Sixty middle and advanced liver cancer patients who had sorafenib targeted therapy from July 2015 to July 2017 in Chinese Medicine Hospital Affiliated to Xinjiang Medical University were enrolled. Contrast-enhanced CT, two-dimensional contrast-enhanced ultrasonography(3D-CEUS) and 3D-CEUS were performed before and after therapy. Display rate and display quality score of tumor nourishing vessels, sensitivity, specificity and accuracy of tumor inactivation diagnosis were analyzed between 3D-CEUS and 2D-CEUS. Results    In 60 tumor lesions, the display rate of arterial phase tumor nourishing vessels of 2D-CEUS was 66.7% (40/60), and the display rate of 3D-CEUS was 100.0% (60/60), which was significantly higher than that of 2D-CEUS(χ2=5.459, P=0.027). Display quality score of arterial phase tumor nourishing vessels also showed a significant difference between 3D-CEUS and 2D-CEUS[3D-CEUS: 5 cases of 1 point, 22 cases of 2 points, 33 cases of 3 points; 2D-CEUS: 29 cases of 1 point, 24 cases of 2 points, 7 cases of 3 points](P=0.023). After treatment, sensitivity, specificity and accuracy of tumor inactivation diagnosis showed no significant differences between 3D-CEUS and 2D-CEUS(P>0.05). Conclusion    Both 2D-CEUS and 3D-CEUS have high values in evaluating the effectiveness of sorafenib targeted therapy for middle and advanced liver cancer; 3D-CEUS is more effective in displaying tumor nourishing vessels.

    【Key words】Liver neoplasms;Real-time three-dimensional ultrasonography;Sorafenib;Targeted therapy

    【Fund program】Natural Science Foundation of Xinjiang Uygur Autonomous Region(2016D01C133)


copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭